Controlled release of cyclosporine A self-nanoemulsifying systems from osmotic pump tablets: Near zero-order release and pharmacokinetics in dogs

International Journal of Pharmaceutics

Volumn 452, Issue 1-2, 2013, Pages 233-240

  Zhang, Xi ^a   Yi, Yueneng ^a   Qi, Jianping ^a   Lu, Yi ^a   Tian, Zhiqiang ^a   Xie, Yunchang ^a   Yuan, Hailong ^b   Wu, Wei ^a  

^a FUDAN UNIVERSITY   (China)

^b BEIJING 302 HOSPITAL   (China)

Author keywords

Controlled release; Cyclosporine A; Drug delivery; Osmotic tablet; Self nanoemulsifying

Indexed keywords

ACETYLSALICYLIC ACID; CELLULOSE ACETATE; CREMOPHOR; CYCLOSPORIN A; DIETHYLENE GLYCOL MONOETHYL ETHER; LACTOSE; MACROGOL; SUCROSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD SAMPLING; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DOG; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; NANOEMULSION; NONHUMAN; OSMOTIC PRESSURE; OSMOTIC PUMP; PARTICLE SIZE; PRIORITY JOURNAL; TABLET; THICKNESS; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84884202889     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.05.014     Document Type: Article

References (38)

1. Bogusz, M.J., Enazi, E.A., Hassan, H., Abdel-Jawaad, J., Ruwaily, J.A., Tufail, M.A., 2007. Simultaneous LC-MS-MS determination of cyclosporine A, tacrolimus, and sirolimus in whole blood as well as mycophenolic acid in plasma using common pretreatment procedure. J. Chromtogr. B 850, 471-480.
2. Cui, J., Yu, B., Zhao, Y., Zhu, W., Li, H., Lou, H., Zhai, G., 2009. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int. J. Pharm. 371, 148-155.
3. Czogalla, A., 2009. Oral cyclosporine A - the current picture of its liposomal and other delivery systems. Cell. Mol. Biol. Lett. 14, 139-152.
4. Dunn, C.J., Wagstaff, A.J., Perry, C.M., Plosker, G.L., Goa, K.L., 2001. Cyclosporin: an updated review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (neoral)1 in organ transplantation. Drugs 61, 1957-2016.
5. Fang, Z.G., You, B.G., Chen, Y.G., Zhang, J.K., Liu, Y.Q., Zhang, X.N., Zhang, Q., 2010. Analysis of cyclosporine A and its metabolites in rat urine and feces by liquid chromatography-tandem mass spectrometry. J. Chromtogr. B 878, 1153-1162.
6. Guan, P., Lu, Y., Qi, J., Niu, M., Lian, R., Hu, F., Wu, W., 2011. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int. J. Nanomedicine 6, 965-974.
7. Hu, X., Lin, C., Chen, D., Zhang, J., Liu, Z., Wu, W., Song, H., 2012. Sirolimus solid self-microemulsifying pellets: formulation development, characterization and bioavailability evaluation. Int. J. Pharm. 438, 123-133.
8. Kang, B.K., Chon, S.K., Kim, S.H., Jeong, S.Y., Kim, M.S., Cho, S.H., Lee, H.B., Khang, G., 2004. Controlled release of paclitaxel from microemulsion containing PLGA and evaluation of anti-tumor activity in vitro and in vivo. Int. J. Pharm. 286, 147-156.
9. Kovarik, J.M., Mueller, E.A., van Bree, J.B., Fluckiger, S.S., Lange, H., Schmidt, B., Boesken, W.H., Lison, A.E., Kutz, K., 1994. Cyclosporine pharmacokinetics and variability from a microemulsion formulation - a multicenter investigation in kidney transplant patients. Transplantation 58, 658-663. (Pubitemid 24317763)
10. Lai, J., Lu, Y., Yin, Z., Hu, F., Wu, W., 2010. Pharmacokinetics and enhanced oral bioavailability in beagle dogs of cyclosporine A encapsulated in glyceryl monooleate/poloxamer 407 cubic nanoparticles. Int. J. Nanomedicine 5, 13-23.
11. Lei, Y., Lu, Y., Qi, J., Nie, S., Hu, F., Pan, W., Wu, W., 2011. Solid self-nanoemulsifying cyclosporin A pellets prepared by fluid-bed coating: preparation, characterization and in vitro redispersibility. Int. J. Nanomedicine 6, 795-805.
12. Lei, Y., Qi, J., Nie, S., Hu, F., Pan, W., Lu, Y., Wu, W., 2012. Solid self-nanoemulsifying cyclosporine A pellets prepared by fluid-bed coating: stability and bioavailability study. J. Biomed. Nanotechnol. 8, 515-521.
13. Lepage, J.M., Lelong-Boulouard, V., Lecouf, A., Debruyne, D., Hurault de Ligny, B., Coquerel, A., 2007. Cyclosporine monitoring in peripheral blood mononuclear cells: feasibility and interest. A prospective study on 20 renal transplant recipients. Transplant. P. 39, 3109-3110. (Pubitemid 350251404)
14. Li, H., Yin, X., Ji, J., Sun, L., Shao, Q., York, P., Xiao, T., He, Y., Zhang, J., 2012. Microstructural investigation to the controlled release kinetics of monolith osmotic pump tablets via synchrotron radiation X-ray microtomography. Int. J. Pharm. 427, 270-275.
15. Lu, Y., Qi, J., Wu, W., 2012. Absorption, disposition and pharmacokinetics of nanoemulsions. Curr. Drug Metab. 13, 396-417.
16. Milovic, M., Djuris, J., Djekic, L., Vasiljevic, D., Ibric, S., 2012. Characterization and evaluation of solid self-microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release. Int. J. Pharm. 436, 58-65.
17. Naito, M., Takei, T., Eguchi, A., Uchida, K., Tsuchiya, K., Nitta, K., 2008. Monitoring of blood cyclosporine concentration in steroid-resistant nephrotic syndrome. Intern. Med. 47, 1567-1572.
18. Nazzal, S., Khan, M.A., 2006. Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int. J. Pharm. 315, 110-121. (Pubitemid 43674113)
19. Noble, S., Markham, A., 1995. Cyclosporin. A review of the pharmacokinetic properties, clinical efficacy and tolerability of a microemulsion-based formulation (Neoral). Drugs 50, 924-941.
20. Park, M.J., Balakrishnan, P., Yang, S.G., 2012. Polymeric nanocapsules with SEDDS oil-core for the controlled and enhanced oral absorption of cyclosporine. Int. J. Pharm., http://dx.doi.org/10.1016/j.ijpharm.2012.1010. 1018.
21. Porter, C.J., Trevaskis, N.L., Charman, W.N., 2007. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs. Nat. Rev. Drug Discov. 6, 231-248. (Pubitemid 46344627)
22. Pouton, C.W., Porter, C.J., 2008. Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv. Drug Deliver. Rev. 60, 625-637.
23. Prasad, R., Singh, U.K., Mittal, R., Mishra, O.P., 2011. Immunosuppressive therapy in children. J. Indian Med. Assoc. 109, 104-107.
24. Setthacheewakul, S., Mahattanadul, S., Phadoongsombut, N., Pichayakorn, W., Wiwattanapatapee, R., 2010. Development and evaluation of self-microemulsifying liquid and pellet formulations of curcumin, and absorption studies in rats. Eur. J. Pharm. Biopharm. 76, 475-485.
25. Theeuwes, F., 1975. Elementary osmotic pump. J. Pharm. Sci. 64, 1987-1991.
26. Verma, R.K., Mishra, B., Garg, S., 2000. Osmotically controlled oral drug delivery. Drug Dev. Ind. Pharm. 26, 695-708. (Pubitemid 30397323)
27. Villar, A.M., Naveros, B.C., Campmany, A.C., Trenchs, M.A., Rocabert, C.B., Bellowa, L.H., 2012. Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. Int. J. Pharm. 431, 161-175.
28. Wang, Y., Sun, J., Zhang, T., Liu, H., He, F., He, Z., 2011. Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems. Drug Dev. Ind. Pharm. 37, 1225-1230.
29. Warrens, A.N., Waters, J.B., Salama, A.D., Lechler, R.I., 1999. Improving the therapeutic monitoring of cyclosporin A. Clin. Transplant. 13, 193-200. (Pubitemid 29155249)
30. Wei, L., Li, J., Guo, L., Nie, S., Pan, W., Sun, P., Liu, H., 2007. Investigations of a novel self-emulsifying osmotic pump tablet containing carvedilol. Drug Dev. Ind. Pharm. 33, 990-998. (Pubitemid 47463810)
31. Wu, W., Wang, Y., Que, L., 2006. Enhanced bioavailability of silymarin by self-microemulsifying drug delivery system. Eur. J. Pharm. Biopharm. 63, 288-294. (Pubitemid 43776222)
32. Xie, Y., Lu, Y., Qi, J., Li, X., Zhang, X., Han, J., Jin, S., Yuan, H., Wu, W., 2012. Synchronized and controlled release of multiple components in silymarin achieved by the osmotic release strategy. Int. J. Pharm., http://dx.doi.org/10.1016/j.ijpharm.2012.1012.1007.
33. Yi, T., Wan, J., Xu, H., Yang, X., 2008. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose. Eur. J. Pharm. Sci. 34, 274-280.
34. Zhang, Y., Wang, R., Wu, J., Shen, Q., 2012. Characterization and evaluation of self-microemulsifying sustained-release pellet formulation of puerarin for oral delivery. Int. J. Pharm. 427, 337-344.
35. Zhang, Z.H., Dong, H.Y., Peng, B., Liu, H.F., Li, C.L., Liang, M., Pan, W.S., 2011. Design of an expert system for the development and formulation of push-pull osmotic pump tablets containing poorly water-soluble drugs. Int. J. Pharm. 410, 41-47.
36. Zhao, Y., Wang, C., Chow, A.H., Ren, K., Gong, T., Zhang, Z., Zheng, Y., 2010. Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of Zedoary essential oil: formulation and bioavailability studies. Int. J. Pharm. 383, 170-177.
37. Zvonar, A., Berginc, K., Kristl, A., Gasperlin, M., 2010. Microencapsulation of self-microemulsifying system: improving solubility and permeability of furosemide. Int. J. Pharm. 388, 151-158.
38. Zvonar, A., Bolko, K., Gasperlin, M., 2012. Microencapsulation of self-microemulsifying systems: optimization of shell-formation phase and hardening process. Int. J. Pharm. 437, 294-302.